# Study to Improve Survival Among HIV-Exposed Infants in Botswana

> **NCT01229761** · PHASE2 · COMPLETED · sponsor: **Harvard School of Public Health (HSPH)** · enrollment: 3724 (estimated)

## Conditions studied

- HIV Infections
- Neutropenia
- Anemia

## Interventions

- **DRUG:** cotrimoxazole prophylaxis
- **DRUG:** cotrimoxazole placebo
- **BEHAVIORAL:** exclusive breastfeeding until 6 months of age
- **BEHAVIORAL:** breastfeeding for 12 months

## Key facts

- **NCT ID:** NCT01229761
- **Lead sponsor:** Harvard School of Public Health (HSPH)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-03
- **Final completion:** 2018-10
- **Target enrollment:** 3724 (ESTIMATED)
- **Last updated:** 2019-09-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01229761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01229761, "Study to Improve Survival Among HIV-Exposed Infants in Botswana". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01229761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*